Sage Makes Deep Cuts, Axing 53% Of The Workforce, As It Reins In Zulresso
The company will cut 340 positions, primarily affecting Zulresso commercial operations, to save $170m, after announcing it will need to run new trials to support the regulatory plan for zuranolone.